CaroGen
Phase 1CaroGen Corporation leads in immunotherapy and vaccine development, using its RNA-based AVIDIO platform for cancer and hepatitis B therapies, backed by NIH and DoD funding.
Founded
2016
Focus
BiologicsViral Technology
About
CaroGen Corporation leads in immunotherapy and vaccine development, using its RNA-based AVIDIO platform for cancer and hepatitis B therapies, backed by NIH and DoD funding.
Funding History
2Total raised: $20M
Series A$15MNorthpond VenturesOct 15, 2023
Seed$5MYale UniversityJun 15, 2022
Company Info
TypePrivate
Founded2016
LocationFarmington, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile